Literature DB >> 24297599

Physicochemical characterization of 9-aminocamptothecin in aqueous solutions.

Shahidur Rahman1, Deval Patel, Michalakis Savva.   

Abstract

The present manuscript provides a detailed physicochemical and thermodynamic characterization of 9-aminocamptothecin (9AC) which can be used as a tool to develop novel formulation strategies for optimum pharmacological activity. The pKa of 9AC was determined to be 2.43 at 37°C, while the basicity of quinoline nitrogen of 9AC was found to decrease with increasing temperature due to a positive enthalpy of deprotonation of 10.36 kJ mol(-1). The equilibrium solubility as well as the intrinsic solubility of the drug was found to increase with increasing temperature and decreasing pH. The enthalpies of solution of unionized and ionized forms of 9AC obtained from isothermal and iso-pH equilibrium solubility measurements were found to be 36.01 and 24.72 kJ mol(-1), respectively. Equilibrium hydrolysis studies revealed the hydrolytic susceptibility of 9AC with only 14% of active lactone species remaining at physiological pH 7.4. The intrinsic partition coefficient log P of the free base, 9AC-lactone, was estimated to be 1.28 (a characteristic of molecules suitable for oral absorption). The estimated pKa and log P values of 9AC, combined with its increased solubility at lower pH, are features that can be utilized to develop novel drug delivery systems to optimize the antitumor activity of 9AC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297599      PMCID: PMC3909166          DOI: 10.1208/s12249-013-0046-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

Review 1.  Topoisomerase I poisons and suppressors as anticancer drugs.

Authors:  C Bailly
Journal:  Curr Med Chem       Date:  2000-01       Impact factor: 4.530

2.  Physicochemical characterization and membrane binding properties of camptothecin.

Authors:  Bilge Selvi; Sanjay Patel; Michalakis Savva
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

Review 3.  Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer.

Authors:  Hiroshi Nakagawa; Hikaru Saito; Yoji Ikegami; Sachiko Aida-Hyugaji; Seigo Sawada; Toshihisa Ishikawa
Journal:  Cancer Lett       Date:  2005-11-23       Impact factor: 8.679

4.  Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer.

Authors:  Song-Qi Gao; Zheng-Rong Lu; Boris Petri; Pavla Kopečková; Jindřich Kopeček
Journal:  J Control Release       Date:  2005-11-10       Impact factor: 9.776

5.  Thermodynamic studies and loading of 7-ethyl-10-hydroxycamptothecin into mesoporous silica particles MCM-41 in strongly acidic solutions.

Authors:  Rishi Thakur; Balasubramanian Sivakumar; Michalakis Savva
Journal:  J Phys Chem B       Date:  2010-05-06       Impact factor: 2.991

Review 6.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

Review 7.  Topoisomerase 1 inhibitors and cancer therapy.

Authors:  Julia Moukharskaya; Claire Verschraegen
Journal:  Hematol Oncol Clin North Am       Date:  2012-06       Impact factor: 3.722

8.  The structural basis of camptothecin interactions with human serum albumin: impact on drug stability.

Authors:  T G Burke; Z Mi
Journal:  J Med Chem       Date:  1994-01-07       Impact factor: 7.446

9.  Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551.

Authors:  Nancy L Bartlett; Jeffrey L Johnson; Nina Wagner-Johnston; Mark J Ratain; Bruce A Peterson
Journal:  Cancer Chemother Pharmacol       Date:  2008-07-23       Impact factor: 3.333

Review 10.  Cancer therapies utilizing the camptothecins: a review of the in vivo literature.

Authors:  Vincent J Venditto; Eric E Simanek
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

View more
  1 in total

1.  A Biophysical Insight of Camptothecin Biodistribution: Towards a Molecular Understanding of Its Pharmacokinetic Issues.

Authors:  Andreia Almeida; Eduarda Fernandes; Bruno Sarmento; Marlene Lúcio
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.